中電信(00728.HK)和聯通(00762.HK)聯合推共建共享區塊鏈調度平臺
據中國電信微博消息,由中電信(00728.HK)和聯通(00762.HK)聯合自主研發的共建共享區塊鏈調度平臺近日在2021年中國國際信息通信展覽會上首次亮相。雙方聯合推出自主研發的共建共享區塊鏈調度平臺。
該調度平臺是首個基於區塊鏈的跨運營商5G運營調度系統。同時,雙方以區塊鏈技術爲基礎,構建多方共享互通互信的數據底座,通過充分調用雙方雲、大數據及現有系統能力,在天宮雲與天翼雲統一部署、跨雲組鏈,共同打造聯合數據管理、聯合網絡規劃、聯合建設調度、聯合運營分析、聯合辦公協同等五大應用能力。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.